🇺🇸 FDA
Pipeline program

SOF

GS-US-334-1112

Phase 2 small_molecule completed

Quick answer

SOF for Hepatitis C Virus Infection is a Phase 2 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Hepatitis C Virus Infection
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials